These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1438445

  • 1. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
    Skala JP, Rogers PC, Chan KW, Khangura SS, Rodriguez WC.
    Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
    [No Abstract] [Full Text] [Related]

  • 2. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP, Rogers PC, Chan KW, Rodriguez WC.
    Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS, Park HM, Han CH, Park JW, Kim CC, Kim DJ.
    Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
    [No Abstract] [Full Text] [Related]

  • 4. Purging with 4-hydroperoxycyclophosphamide combinations.
    Jones RJ, Miller CB, Rowley SD.
    Prog Clin Biol Res; 1992; 377():1-9; discussion 10-1. PubMed ID: 1438406
    [No Abstract] [Full Text] [Related]

  • 5. Purging of acute lymphoblastic leukemia by long-term marrow culture.
    Douay L, Ozsahin H, Barbu V, Fabrega S, Giarratana MC, Da WM, Allieri A, Gorin NC.
    Prog Clin Biol Res; 1992; 377():205-13; discussion 214. PubMed ID: 1438417
    [No Abstract] [Full Text] [Related]

  • 6. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B, Makrynikola V, Bradstock K.
    Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
    [No Abstract] [Full Text] [Related]

  • 7. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 8. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V, Kabral A, Bradstock KF.
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [Abstract] [Full Text] [Related]

  • 9. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 10. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
    Skala JP, Rogers PC, Chan KW, Chao HY, Rodriguez WC.
    Prog Clin Biol Res; 1992 Sep; 377():71-8. PubMed ID: 1438447
    [No Abstract] [Full Text] [Related]

  • 11. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow purging with antisense oligodeoxynucleotides.
    Gewirtz AM.
    Prog Clin Biol Res; 1992 Jul; 377():215-24; discussion 225-6. PubMed ID: 1438418
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF, Merle PA, Steenbergen EJ, van Leeuwen EF, von dem Borne AE, Slaper-Cortenbach IC.
    Prog Clin Biol Res; 1994 Jul; 389():601-9. PubMed ID: 7700926
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
    Verdonck LF, Witteveen EO, van Heugten HG, Rozemuller E, Rijksen G.
    Cancer Res; 1990 Jul 01; 50(13):4020-5. PubMed ID: 2354451
    [Abstract] [Full Text] [Related]

  • 20. [Autologous bone marrow transplantation in acute lymphoblastic leukemia].
    Tura S, Visani G, Gamberi B.
    Haematologica; 1991 Jun 01; 76 Suppl 3():327-36. PubMed ID: 1684347
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.